Neurological Disorder Diagnostics Market Report for Executives – Strategic Outlook Through 2034

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 

 What are the growth projections for the neurological disorder diagnostics market from 2024 to 2029?
 The neurological disorder diagnostics market size has grown strongly in recent years. It will grow from $11.75 $ billion in 2024 to $12.61 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increase in prevalence of neurological disorders, increase in ageing population, growth in emphasis on early diagnosis and disease management, growth in awareness of neurological disorders, and increase focus on early diagnosis.
 
 The neurological disorder diagnostics market size is expected to see strong growth in the next few years. It will grow to $16.6 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing awareness and education, increasing healthcare expenditure, improved access to healthcare services, expansion of diagnostic centers, and rising adoption of personalized medicine. Major trends in the forecast period include advancements in neuroimaging techniques, adoption of wearable devices and remote monitoring technologies, advancements in biomarker discovery and genetic testing, integration of artificial intelligence and machine learning, and development of point-of-care diagnostic devices.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=19611&type=smp
 
 What strategic initiatives by market players are driving neurological disorder diagnostics industry growth?
 The increasing prevalence of Alzheimer’s disease is expected to propel the growth of the neurological disorder diagnostics market going forward. Alzheimer’s disease refers to a progressive neurodegenerative disorder characterized by a gradual decline in cognitive functions, including memory, reasoning, and problem-solving. Alzheimer’s disease combines genetic factors, such as specific gene mutations and variations, the accumulation of amyloid plaques and tau tangles in the brain, chronic inflammation, vascular issues, and lifestyle factors. Neurological disorder diagnostics help Alzheimer’s disease by enabling early and accurate detection through advanced imaging techniques, biomarker analysis, and cognitive assessments. For instance, in September 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, approximately 411,100 individuals in Australia were living with dementia, including around 257,500 women and 153,700 men. Thus, the increasing prevalence of Alzheimer’s disease is driving the growth of the neurological disorder diagnostics market.
 
 What emerging segments are shaping the future landscape of the neurological disorder diagnostics industry?
 The neurological disorder diagnosticsmarket covered in this report is segmented –
 
 1) By Component: Instruments, Reagents, Kits, Software, Services
 2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques
 3) By Disease Type: Alzheimer’s Disease, Dementia, Parkinson’s Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types
 4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes
 
 Subsegments:
 1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,
 2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents
 3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders
 4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software
 5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/neurological-disorder-diagnostics-global-market-report
 
 What technological trends are expected to redefine the neurological disorder diagnostics market?
 Major companies operating in the neurological disorder diagnostics market are focused on developing innovative solutions, such as neurological disease quantification software, for one billion individuals affected by neurological diseases worldwide. Neurological disease quantification software is a tool used to measure and analyze brain function and disease progression in neurological conditions. For instance, in January 2024, Quibim, a Spain-based biotechnology company, launched the QP-Brain, an AI-based early-stage neurological disease quantification software. QP-Brain by Quibim is advanced neuroimaging analysis software designed to quantify brain tissue alterations in neurological diseases. Its unique features include AI-powered automated segmentation and detailed volumetric analysis, offering precise insights into brain structure changes for clinical and research applications.
 
 How are key players in the neurological disorder diagnostics market strengthening their market position?
 Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co. Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation
 
 Which geographic areas are contributing significantly to the growth of the neurological disorder diagnostics sector?
 North America was the largest region in the neurological disorder diagnostics market in 2024. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Neurological Disorder Diagnostics Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19611
 
 Need Customized Data On Neurological Disorder Diagnostics Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=19611&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Americas +1 310–496-7795
 Europe +44 7882 955267
 Asia & Others +44 7882 955267 & +91 8897263534
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company